Box–Behnken design based development of UV-reversed phase high performance liquid chromatographic method for determination of ascorbic acid in tablet formulations

Syed Najmul Hejaz Azmi and Umaima Al Hoqani and Juhaina Obaid Said Al Mamari and Buthain Mohamed Salim Al Mamari and Balaqis Sultan Ali Rashid Al Jassasi and Aziza Saleh Saif Al Rubaiai and Nafisur Rahman and Mohd Nasir and Sk Manirul Haque and Shah Alam Khan and Qamar Uddin Ahmed and Zainul Amiruddin Zakaria (2022) Box–Behnken design based development of UV-reversed phase high performance liquid chromatographic method for determination of ascorbic acid in tablet formulations. Separations, 9. pp. 1-21.

[img] Text
FULL TEXT.pdf
Restricted to Registered users only

Download (2MB)

Abstract

A simple, sensitive, accurate and inexpensive UV-reversed-phase high-performance liquid chromatographic method was developed for the determination of ascorbic acid in tablet formulations. The method was based on the separation of ascorbic acid using a mobile phase of an acetonitrile NaH₂PO₄ -H₃PO₄ buffer solution (pH = 3) (5:95 v/v) with a UV detection wavelength of 245 nm and a flow rate of 0.8 mL min⁻¹ at ambient column temperature. The variables of the proposed method, such as acetonitrile fraction (%), flow rate (mL min⁻¹) and column temperature (◦C), were optimized on the peak area by response surface methodology via the Box–Behnken design. The mobile phase was passed isocratically, and the separation of ascorbic acid was performed at the retention time of 4.1 min. A calibration graph was obtained and found to be linear in the concentration range of 10–180 µg mL⁻¹. The method suitability was assessed and an asymmetry factor of 1.15 was obtained. The proposed method was successfully applied for the determination of ascorbic acid in tablet formulations and statistically compared with the results of the reference method. The performance of the proposed method was excellent and in agreement with the reference method. The recovery percentage of the proposed and reference methods was in the range of 99.98–100.04% and showed compliance (100 ± 2%) with regulatory guidelines

Item Type: Article
Keyword: Ascorbic acid, Box–Behnken design, HPLC, ICH, Validation
Subjects: Q Science > QD Chemistry > QD1-999 Chemistry
R Medicine > R Medicine (General) > R5-920 Medicine (General)
Department: FACULTY > Faculty of Medicine and Health Sciences
Depositing User: SITI AZIZAH BINTI IDRIS -
Date Deposited: 07 Jan 2025 11:39
Last Modified: 07 Jan 2025 11:39
URI: https://eprints.ums.edu.my/id/eprint/42525

Actions (login required)

View Item View Item